AppliedVR teamed up with the National Cancer Institute to study the feasibility of VR to alleviate anxiety in brain tumor patients undergoing imaging scans. The research partners recently announced interim analysis results from their clinical study — they said that not only would VR intervention be a feasible option to reduce patients’ anxiety, but that patients would report high satisfaction levels as well.
Intracranial brachytherapy was recently improved through the development of a surgically targeted radiation therapy comprised of Cesium-131 radiation seeds embedded in a bioresorbable collagen tile.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Celldex's brain cancer vaccine improves survival rates and, importantly, improves quality of life, according to new topline results just released by the company.
The market for newly diagnosed brain cancer therapies is in serious need of new innovation – few therapies exist on the market for this indication. Diffusion Pharmaceuticals, a 13-year-old Virginia biotech in the midst of mid-stage clinical trials for brain cancer, just raised about $3.5 million, according to a regulatory filing. The company’s most advanced drug […]